|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | (2006.01) |
| A61K2035/124 | (2013.01) | ||
| C12N 5/00 | (2006.01) | ||
| C07K 16/28 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/283 | (2013.01) | ||
| C07K 16/32 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 49/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K 14/735 | (2006.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C12N 5/0646 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N2501/23 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| C12N2503/00 | (2013.01) | ||
| A61K 35/12 | (2015.01) | ||
| C12N2503/02 | (2013.01) | ||
| C12N2510/00 | (2013.01) | ||
| G01N 33/5011 | (2013.01) | ||
| G01N 33/5047 | (2013.01) | ||
| C07K 14/70535 | (2013.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3406631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18169049.6 |
| Date of filing the European patent application | 2005-07-08 | |
| (97) | Date of publication of the European application | 2018-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 586581 P | 2004-07-10 | US |
| (72) |
CAMPBELL, Kerry S. , US
|
| (73) |
The Institute for Cancer Research ,
333 Cottman Avenue, Philadelphia, PA 19111,
US
|
| (54) | GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES |
| GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES |